We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > STEER

News List

Novartis Announces New Phase 3 Study for Spinal Muscular Atrophy Treatment in Elderly Patients americanpharmaceuticalreview
August 04, 2021
Novartis announced that the U.S. FDA determined that OAV-101 intrathecal (IT) clinical trials for spinal muscular atrophy (SMA) patients may proceed, thereby lifting the partial clinical trial hold initiated in October 2019.
STEER appoints Subodh Jindal as CEO expresspharma
December 17, 2020
He will be responsible for business strategy and plant operations for the engineering business with focused attention to fast-emerging fields of pharma continuous manufacturing solutions, plastic recycling solutions, and the food processing industry.